Evidence map›Paper›PMID 29619366›Full record

ArticleFrontiers in chemistry2018

Targeting Endoplasmic Reticulum and/or Mitochondrial Ca

Rosella Scrima, Claudia Piccoli, Darius Moradpour, Nazzareno Capitanio

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. HCV-induced autophagy and innate immunity.Frontiers in immunology · 2024
    Review
  3. Review
  4. Hepatocytes: A key role in liver inflammation.Frontiers in immunology · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Role of Mitochondria in Viral Infections.Life (Basel, Switzerland) · 2021
    Review
  9. Targeting CaCancers · 2020
    Review
  10. Viroporins and inflammasomes: A key to understand virus-induced inflammation.The international journal of biochemistry & cell biology · 2020
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Rosella ScrimaDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Claudia PiccoliDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Darius MoradpourService of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Nazzareno CapitanioDepartment of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
University of Foggia · ITUniversity Hospital of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic hepatitis C is characterized by metabolic disorders and by a microenvironment in the liver dominated by oxidative stress, inflammation and regeneration processes that can in the long term lead to liver cirrhosis and hepatocellular carcinoma. Several lines of evidence suggest that mitochondrial dysfunctions play a central role in these processes. However, how these dysfunctions are induced by the virus and whether they play a role in disease progression and neoplastic transformation remains to be determined. Most

Indexed as

calcium channelsHCVmitochondria associated membranes (MAM)oxidative phosphorylationredox signalingviroporin

Identifiers

PMID29619366
PMCPMC5871704
OpenAlexW2790548352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.